7-[2-(6-chloroimidazo[1,2-a]pyridin-3-yl)pyrimidin-4-yl]-1,2,5,6,8,8a-hexahydroimidazo[1,5-a]pyrazin-3-one;2-[2-(6-chloroimidazo[1,2-a]pyridin-3-yl)pyrimidin-4-yl]-1,3,4,8,9,9a-hexahydropyrazino[1,2-c][1,3]oxazin-6-one;2-[2-(6-chloroimidazo[1,2-a]pyridin-3-yl)pyrimidin-4-yl]-3,4,7,8,9,9a-hexahydro-1H-pyrazino[1,2-c]pyrimidin-6-one;7-[2-(6-chloroimidazo[1,2-a]pyridin-3-yl)pyrimidin-4-yl]-5,6,8,8a-tetrahydro-1H-[1,3]oxazolo[3,4-a]pyrazin-3-one;6-chloro-3-[4-[3-(1H-pyrazol-4-yl)piperidin-1-yl]pyrimidin-2-yl]imidazo[1,2-a]pyridine;3-[4-[3-(1H-pyrazol-4-yl)piperidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyridine
C109H102Cl5F3N40O6 — CID 157318378
Data last refreshed: (MolForge compound catalog, from PubChem)
About 7-[2-(6-chloroimidazo[1,2-a]pyridin-3-yl)pyrimidin-4-yl]-1,2,5,6,8,8a-hexahydroimidazo[1,5-a]pyrazin-3-one;2-[2-(6-chloroimidazo[1,2-a]pyridin-3-yl)pyrimidin-4-yl]-1,3,4,8,9,9a-hexahydropyrazino[1,2-c][1,3]oxazin-6-one;2-[2-(6-chloroimidazo[1,2-a]pyridin-3-yl)pyrimidin-4-yl]-3,4,7,8,9,9a-hexahydro-1H-pyrazino[1,2-c]pyrimidin-6-one;7-[2-(6-chloroimidazo[1,2-a]pyridin-3-yl)pyrimidin-4-yl]-5,6,8,8a-tetrahydro-1H-[1,3]oxazolo[3,4-a]pyrazin-3-one;6-chloro-3-[4-[3-(1H-pyrazol-4-yl)piperidin-1-yl]pyrimidin-2-yl]imidazo[1,2-a]pyridine;3-[4-[3-(1H-pyrazol-4-yl)piperidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyridine
7-[2-(6-chloroimidazo[1,2-a]pyridin-3-yl)pyrimidin-4-yl]-1,2,5,6,8,8a-hexahydroimidazo[1,5-a]pyrazin-3-one;2-[2-(6-chloroimidazo[1,2-a]pyridin-3-yl)pyrimidin-4-yl]-1,3,4,8,9,9a-hexahydropyrazino[1,2-c][1,3]oxazin-6-one;2-[2-(6-chloroimidazo[1,2-a]pyridin-3-yl)pyrimidin-4-yl]-3,4,7,8,9,9a-hexahydro-1H-pyrazino[1,2-c]pyrimidin-6-one;7-[2-(6-chloroimidazo[1,2-a]pyridin-3-yl)pyrimidin-4-yl]-5,6,8,8a-tetrahydro-1H-[1,3]oxazolo[3,4-a]pyrazin-3-one;6-chloro-3-[4-[3-(1H-pyrazol-4-yl)piperidin-1-yl]pyrimidin-2-yl]imidazo[1,2-a]pyridine;3-[4-[3-(1H-pyrazol-4-yl)piperidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyridine (PubChem CID 157318378) has the molecular formula C109H102Cl5F3N40O6 and a molecular weight of 2302.55 g/mol. Its IUPAC name is 7-[2-(6-chloroimidazo[1,2-a]pyridin-3-yl)pyrimidin-4-yl]-1,2,5,6,8,8a-hexahydroimidazo[1,5-a]pyrazin-3-one;2-[2-(6-chloroimidazo[1,2-a]pyridin-3-yl)pyrimidin-4-yl]-1,3,4,8,9,9a-hexahydropyrazino[1,2-c][1,3]oxazin-6-one;2-[2-(6-chloroimidazo[1,2-a]pyridin-3-yl)pyrimidin-4-yl]-3,4,7,8,9,9a-hexahydro-1H-pyrazino[1,2-c]pyrimidin-6-one;7-[2-(6-chloroimidazo[1,2-a]pyridin-3-yl)pyrimidin-4-yl]-5,6,8,8a-tetrahydro-1H-[1,3]oxazolo[3,4-a]pyrazin-3-one;6-chloro-3-[4-[3-(1H-pyrazol-4-yl)piperidin-1-yl]pyrimidin-2-yl]imidazo[1,2-a]pyridine;3-[4-[3-(1H-pyrazol-4-yl)piperidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyridine.
Molecular Properties
| Compound Name | 7-[2-(6-chloroimidazo[1,2-a]pyridin-3-yl)pyrimidin-4-yl]-1,2,5,6,8,8a-hexahydroimidazo[1,5-a]pyrazin-3-one;2-[2-(6-chloroimidazo[1,2-a]pyridin-3-yl)pyrimidin-4-yl]-1,3,4,8,9,9a-hexahydropyrazino[1,2-c][1,3]oxazin-6-one;2-[2-(6-chloroimidazo[1,2-a]pyridin-3-yl)pyrimidin-4-yl]-3,4,7,8,9,9a-hexahydro-1H-pyrazino[1,2-c]pyrimidin-6-one;7-[2-(6-chloroimidazo[1,2-a]pyridin-3-yl)pyrimidin-4-yl]-5,6,8,8a-tetrahydro-1H-[1,3]oxazolo[3,4-a]pyrazin-3-one;6-chloro-3-[4-[3-(1H-pyrazol-4-yl)piperidin-1-yl]pyrimidin-2-yl]imidazo[1,2-a]pyridine;3-[4-[3-(1H-pyrazol-4-yl)piperidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyridine |
|---|---|
| PubChem CID | 157318378 |
| Molecular Formula | C109H102Cl5F3N40O6 |
| Molecular Weight | 2302.55 g/mol |
| Exact Mass | 2298.73 |
| IUPAC Name | 7-[2-(6-chloroimidazo[1,2-a]pyridin-3-yl)pyrimidin-4-yl]-1,2,5,6,8,8a-hexahydroimidazo[1,5-a]pyrazin-3-one;2-[2-(6-chloroimidazo[1,2-a]pyridin-3-yl)pyrimidin-4-yl]-1,3,4,8,9,9a-hexahydropyrazino[1,2-c][1,3]oxazin-6-one;2-[2-(6-chloroimidazo[1,2-a]pyridin-3-yl)pyrimidin-4-yl]-3,4,7,8,9,9a-hexahydro-1H-pyrazino[1,2-c]pyrimidin-6-one;7-[2-(6-chloroimidazo[1,2-a]pyridin-3-yl)pyrimidin-4-yl]-5,6,8,8a-tetrahydro-1H-[1,3]oxazolo[3,4-a]pyrazin-3-one;6-chloro-3-[4-[3-(1H-pyrazol-4-yl)piperidin-1-yl]pyrimidin-2-yl]imidazo[1,2-a]pyridine;3-[4-[3-(1H-pyrazol-4-yl)piperidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyridine |
| SMILES | Clc1ccc2ncc(-c3nccc(N4CCCC(c5cn[nH]c5)C4)n3)n2c1.FC(F)(F)c1ccc2ncc(-c3nccc(N4CCCC(c5cn[nH]c5)C4)n3)n2c1.O=C1NCC2CN(c3ccnc(-c4cnc5ccc(Cl)cn45)n3)CCN12.O=C1NCCC2CN(c3ccnc(-c4cnc5ccc(Cl)cn45)n3)CCN12.O=C1OCC2CN(c3ccnc(-c4cnc5ccc(Cl)cn45)n3)CCN12.O=C1OCCC2CN(c3ccnc(-c4cnc5ccc(Cl)cn45)n3)CCN12 |
| InChI | InChI=1S/C20H18F3N7.C19H18ClN7.C18H18ClN7O.C18H17ClN6O2.C17H16ClN7O.C17H15ClN6O2/c21-20(22,23)15-3-4-17-25-10-16(30(17)12-15)19-24-6-5-18(28-19)29-7-1-2-13(11-29)14-8-26-27-9-14;20-15-3-4-17-22-10-16(27(17)12-15)19-21-6-5-18(25-19)26-7-1-2-13(11-26)14-8-23-24-9-14;19-12-1-2-15-22-9-14(26(15)10-12)17-20-6-4-16(23-17)24-7-8-25-13(11-24)3-5-21-18(25)27;19-12-1-2-15-21-9-14(25(15)10-12)17-20-5-3-16(22-17)23-6-7-24-13(11-23)4-8-27-18(24)26;18-11-1-2-14-20-8-13(25(14)9-11)16-19-4-3-15(22-16)23-5-6-24-12(10-23)7-21-17(24)26;18-11-1-2-14-20-7-13(24(14)8-11)16-19-4-3-15(21-16)22-5-6-23-12(9-22)10-26-17(23)25/h3-6,8-10,12-13H,1-2,7,11H2,(H,26,27);3-6,8-10,12-13H,1-2,7,11H2,(H,23,24);1-2,4,6,9-10,13H,3,5,7-8,11H2,(H,21,27);1-3,5,9-10,13H,4,6-8,11H2;1-4,8-9,12H,5-7,10H2,(H,21,26);1-4,7-8,12H,5-6,9-10H2 |
| InChIKey | BDWKTVGFYSMFIZ-UHFFFAOYSA-N |
| XLogP | 15.74 |
| TPSA | 459.04 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 38 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 163 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2302.55 |
| LogP ≤ 5 | 15.74 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 38 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157318378 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.